FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns new therapeutic regimens of acute viral hepatitis treatment, making it possible to reduce duration of clinical manifestation and preventing transition in the chronic course of the disease. Method of treating acute hepatitis B or C with severe clinical course consists in intravenous drop introduction of preparation 2 times a week for three months, wherein first drop introduction is 4.0 ml of Laennek, dissolved in 250 ml of 0.9 % sodium chloride water solution or 5 % glucose solution, through ulnar vein for 1 hour 20 minutes, second and subsequent introductions consist 10.0 ml of Laennek, dissolved in 250 ml of 0.9 % saline solution through ulnar vein for 1.5 hours.
EFFECT: method of treating acute hepatitis B or C is disclosed.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTRAVENOUS DROPLET COMPOSITION BASED ON PURIFIED PLACENTA HYDROLYSATE (VERSIONS) | 2007 |
|
RU2356561C1 |
| USE OF PREPARATION LAENNEK FOR TREATING A DISEASE, ASSOCIATED WITH IMPAIRED IMMUNITY, WHICH IS A CHRONIC RECURRENT HERPES, ATOPIC DERMATITIS OR PSORIASIS | 2015 |
|
RU2599038C1 |
| USE OF PREPARATION LAENNEK FOR TREATING CIRRHOSIS | 2015 |
|
RU2599040C1 |
| METHOD OF TREATING ACUTE VIRAL HEPATITIS B AND MIXED HEPATITIS (B + C, B + D, B + C + D) | 2010 |
|
RU2446798C2 |
| METHOD OF CHRONIC VIRUS HEPATITIS TREATMENT | 2008 |
|
RU2369403C1 |
| METHOD OF TREATING AND PREVENTING AGE-ASSOCIATED DISEASES | 2018 |
|
RU2709488C1 |
| MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
| METHOD OF COMPLEX PATHOGENETIC THERAPY OF ACUTE FORMS OF VIRAL HEPATITIS B AND MIXED HEPATITES (B+C, B+D, B+C+D) | 2010 |
|
RU2440128C1 |
| METHOD FOR PREDICTION OF IF THERAPY EFFECTIVENESS FOR VIRAL HEPATITIS IN CHILDREN | 2008 |
|
RU2379689C1 |
| METHOD FOR TREATING THE CASES OF CHRONIC VIRUS HEPATITIS | 1999 |
|
RU2180235C2 |
